CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-07 | Amanullah Ashraf See Remarks | Option exercise | +3,334 | 3,334 | ||
| 2018-02-07 | Amanullah Ashraf See Remarks | Option exercise · Restricted Stock Units | −3,334 | 6,666 | ||
| 2018-02-06 | Shukla Sanjay President and CEO | Grant or award · Employee Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2018-02-06 | King David John Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2018-02-06 | Blake John T Senior Vice President, Finance | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2018-02-06 | Amanullah Ashraf See Remarks | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2018-01-02 | MENDLEIN JOHN Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2017-11-13 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Sale | −1,083 | $3.95 | $4K | 3,209,316 |
| 2017-11-10 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Sale | −5,860 | $4.00 | $23K | 3,210,399 |
| 2017-11-09 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Sale | −5,819 | $4.15 | $24K | 3,216,259 |
| 2017-11-08 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Sale | −1,070 | $4.30 | $5K | 3,222,078 |
| 2017-11-01 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Purchase | +24,728 | $4.80 | $119K | 3,223,148 |
| 2017-11-01 | Shukla Sanjay President and CEO | Grant or award · Employee Stock Option (right to buy) | +450,000 | 450,000 | ||
| 2017-10-01 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Purchase | +4,879 | $5.05 | $25K | 3,198,420 |
| 2017-08-31 | SCHIMMEL PAUL Director | Purchase | +94,336 | $2.65 | $250K | 377,917 |
| 2017-08-31 | SCHIMMEL PAUL Director | Purchase · Warrant to Purchase Common Stock | +35,376 | 35,376 | ||
| 2017-08-31 | MENDLEIN JOHN CEO and Director | Purchase | +37,736 | $2.65 | $100K | 367,883 |
| 2017-08-31 | MENDLEIN JOHN CEO and Director | Purchase · Warrant to Purchase Common Stock | +14,151 | 14,151 | ||
| 2017-05-09 | SCHIMMEL PAUL Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-05-09 | Nashat Amir Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 |
Page 12 of 25 · 483 trades